TSI on Hobamine: 'We feel this is going to be very new & very special for our market'
With a new study in healthy humans supporting the safety and efficacy of TSI’s Hobamine-branded 2-Hydroxybenzylamine (2-HOBA), the company is bullish about its potential to support a healthier immuno-inflammatory system.
Source: nutraingredients-usa.com